Donald W. Northfelt - Concepedia

Author

Donald W. Northfelt

Also Known As

C. Giannini, Carla Falkson, D Northfelt, D W Northfelt, D. Northfelt, D. W. NORTHFELT, D. W. Northfelt, D.W. Northfelt, DONALD NORTHFELT, DONALD W. NORTHFELT

486

Publications

11.1K

Citations

H-Index

148

Concepts

All Affiliations

Mayo Clinic in Arizona Mayo Clinic Mayo Clinic in Florida WinnMed Mayo Clinic Hospital

About

Donald W. Northfelt is an author at Mayo Clinic in Arizona specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	29	66	3.3K
2	Health Sciences	14	16	731
3	Engineering	3	3	348
4	Natural Sciences	1	1	51
5	Nursing	1	1	20

Donald W. Northfelt

133

Publications

9.5K

Citations

H-Index

Page 1

	Year	Citations
Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: results of a randomized phase III clinical trial. Donald W. Northfelt, Bruce J. Dezube, James Thommes, Journal of Clinical Oncology Pegylated-liposomal DoxorubicinMedicineImmunologyPharmacologyPathology	1998	639
Adaptive Randomization of Veliparib–Carboplatin Treatment in Breast Cancer Hope S. Rugo, Olufunmilayo I. Olopade, Angela DeMichele, New England Journal of Medicine	2016	543
Adaptive Randomization of Neratinib in Early Breast Cancer John W. Park, Minetta C. Liu, Douglas Yee, New England Journal of Medicine	2016	453
Low-Dose Compared with Standard-Dose m-BACOD Chemotherapy for Non-Hodgkin's Lymphoma Associated with Human Immunodeficiency Virus Infection Lawrence D. Kaplan, David J. Straus, Marcia A. Testa, New England Journal of Medicine	1997	378
Doxorubicin Encapsulated in Liposomes Containing Surface‐Bound Polyethylene Glycol: Pharmacokinetics, Tumor Localization, and Safety in Patients with AIDS‐Related Kaposi's Sarcoma Donald W. Northfelt, Francis J. Martin, Peter K. Working, The Journal of Clinical Pharmacology	1996	375
NeoPalAna: Neoadjuvant Palbociclib, a Cyclin-Dependent Kinase 4/6 Inhibitor, and Anastrozole for Clinical Stage 2 or 3 Estrogen Receptor–Positive Breast Cancer X. Cynthia, Feng Gao, Jingqin Luo, Clinical Cancer Research	2017	359
Personalized circulating tumor DNA analysis to detect residual disease after neoadjuvant therapy in breast cancer Bradon R. McDonald, Tania Contente‐Cuomo, Stephen‐John Sammut, Science Translational Medicine	2019	304
Results of Two Open-Label, Multicenter Phase II Studies of Docetaxel, Platinum Salts, and Trastuzumab in HER2-Positive Advanced Breast Cancer M. Pegram, Tadeusz Pieńkowski, Donald W. Northfelt, JNCI Journal of the National Cancer Institute	2004	271
Association of Event-Free and Distant Recurrence–Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Cancer Douglas Yee, Angela DeMichele, Christina Yau, JAMA Oncology	2020	207
DNA methyltransferase expression in triple-negative breast cancer predicts sensitivity to decitabine Jia Yu, Bo Qin, Ann M. Moyer, Journal of Clinical Investigation Breast OncologyEngineeringCancer BiologyEpigeneticsTumor Biology	2018	204

Page 1